Clinical trial

Anticancer Activity of Nicotinamide on Lung Cancer

NCT02416739

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2015-03-01

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2015-03-01Date precision: month

Registry last updated2020-01-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small-Cell Lung Carcinomaunresolved

Interventions

NicotinamideDRUG

Sponsors & collaborators

Il Yeong Park, Ph.D.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02416739 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.